Patents by Inventor Andy Ommen

Andy Ommen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinazoline derivatives for the treatment of cancer
    Patent number: 7678803
    Abstract: The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula I wherein Q1 is CR1, Q2 is N, Q4 and Q5 are each CR1, Q3 is CR2, X1 is N or CRc, Y is CRc, X2 and X3 are each C(R5)(R6), R7 is O. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer The current invention is also directed toward pharmaceutical compositions comprising compounds of the invention.
    Type: Grant
    Filed: August 24, 2007
    Date of Patent: March 16, 2010
    Assignee: Serenex, Inc.
    Inventors: Kenneth He Huang, James Veal, Thomas Barta, Emilie D. Smith, Wei Ma, Andy Ommen
  • Benzene, Pyridine, and Pyridazine Derivatives
    Publication number: 20080076813
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein A, Q1, Q2, Q3, R3, and R4 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
    Type: Application
    Filed: August 24, 2007
    Publication date: March 27, 2008
    Inventors: Kenneth Huang, Philip Hughes, Wei Ma, Andy Ommen, Angela Woodward, James Veal, Thomas Barta
  • Isoquinoline, Quinazoline and Phthalazine Derivatives
    Publication number: 20080070935
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R0, R5, R6, R7, n, Q1-Q5, Y, and X1-X3 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
    Type: Application
    Filed: August 24, 2007
    Publication date: March 20, 2008
    Inventors: Kenneth Huang, James Veal, Thomas Barta, Emilie Smith, Wei Ma, Andy Ommen